aTyr Pharma (LIFE) Misses Q4 EPS by 3c

aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Webull Corp (BULL) Tops Q2 EPS by 1c
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c